Retrospective Study: Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis
Sponsor study identifier
observational
300
1 country
1
Study Start
October 16, 2018
Actual (reported)Primary Completion
July 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Children treated with intensive chemotherapy are at increased risk for life-threatening infections (sepsis). As the survival of oncology patients increased with the use of aggressive treatment protocols, there was also an increase in the need for hospitalization in intensive care units (ICU) due to sepsis.Several prognostic factors are known to affect the survival of these patients, including the number and type of damaged systems, the type of oncology disease and the duration of neutropenia. With the development of the treatment of ICU, the survival of the oncology patients hospitalized for sepsis has also increased. We will collect demographic details, details of their oncology and infections, laboratory tests and imaging. The goal is to identify prognostic factors in oncologic children hospitalized in ICU due to sepsis, as well as clinical and laboratory parameters that characterize this group of patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 16, 2018
Actual (reported)July 23, 2019
Actual (reported)July 25, 2019
Actual (reported)July 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
survival
survial status 30 day after release from the ICU
30 day
any treatment available by ICU
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Children and youth treated at Schneider Children's Hospital with chemotherapy due to oncology and hospitalized at Schneider Children's Hospital from 2008 until the end of 2018 due to sepsis.
Schneider Children's Medical Center of Israel
Petah Tikva, Israel
Shlomit Barzilai Birenboim, MD
Schneider Children's Medical Center in Israel
First Submitted
July 23, 2019
First Posted
July 25, 2019
Study Start
October 16, 2018
Actual (reported)Primary Completion
July 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
Contact the study team to confirm eligibility.
Study Completion
December 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 22, 2021
Record last verified: 2021-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: